1. Economic Burden of Illness among Persons with Hemophilia B from HUGS Vb: Examining the Association of Severity and Treatment Regimens with Costs and Annual Bleed Rates 
Christina X. Chen, PhD, Judith R. Baker, DrPH, Michael B. Nichol, PhD 
Value in Health 
Volume 20, Issue 8, Pages (September 2017)
DOI: /j.jval
Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Mean annual nonfactor health care services utilization costs by HB severity and treatment regimen. This excludes participants with inhibitors (n = 2). Numeric labels above bars represent total mean per-person health care services utilization costs. Error bars represent 95% confidence intervals for total per-person health care services utilization costs. ER, emergency room; HB, hemophilia B; HTC, hemophilia treatment center.
Value in Health  , DOI: ( /j.jval )
Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3. Fig. 2
Mean annual indirect costs by HB severity and treatment regimen. This excludes participants with inhibitors (n = 2). Numeric labels above bars represent total mean per-person indirect costs. Error bars represent 95% confidence intervals for total per-person indirect costs. HB, hemophilia B.
Value in Health  , DOI: ( /j.jval )
Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions